A Aralex Aachen research explorer

Benjamin Van Hoorick Sign in to save

ORCID 0009-0006-3090-7350 OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

0

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (3)

2× argenx, Ghent, Belgium
1× argenx
1× argenx, Clinical Development, Ghent, Belgium

Papers 4 stored

All · Aachen affiliation only

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
2024 Frontiers in Neurology article Medicine Myasthenia Gravis and Thymoma Open access

87

citations
Long-term safety, tolerability, and efficacy of efgartigimod in patients with generalized myasthenia gravis: Concluding analyses from the ADAPT+ study
2023 Journal of the Neurological Sciences article Medicine Myasthenia Gravis and Thymoma Open access

0

citations
P277 Long-term safety, tolerability, and efficacy of Efgartigimod in patients with Generalized Myasthenia Gravis: concluding analyses from the ADAPT+ study
2023 Neuromuscular Disorders conference-abstract Medicine Myasthenia Gravis and Thymoma

1

citations
Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT+ Study (S5.006)
2023 Neurology article Medicine Myasthenia Gravis and Thymoma

2

citations

4 results